
Sila Damrongsaringkan/iStock via Getty Images
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) and Tandem Diabetes Care (NASDAQ:TNDM) have reached a settlement agreement to resolve all ongoing and potential patent disputes concerning Roche's two European patents and Tandem's t:slim X2 insulin pump.
In total, Tandem will pay Roche $36M over five years, beginning